Error Prone PCR: Principle, Mechanism, and Applications

Identifying improved protein variants requires appropriate screening or selection strategies. Screening assays test individual mutants separately, such as microtiter plate assays using colorimetric detection where substrate hydrolysis produces measurable color changes. Selection strategies link genotype and phenotype in the same compartment, enabling higher throughput. Phage display uses bacteriophages displaying proteins on surfaces; libraries are panned against immobilized targets, enriching for high-affinity binders through multiple rounds. Ribosome display tethers ribosomes to mRNA transcripts, allowing in vitro selection for binding activity. FACS (fluorescence-activated cell sorting) labels active cells fluorescently and sorts millions per hour based on intensity. In vitro compartmentalization creates artificial cells with transcription/translation machinery, maintaining genotype-phenotype linkage without cellular limitations.

Phage antibody library technology enables screening and selection of antibodies with unique properties through cyclic panning—multiple rounds of phage binding to antigen, washing, and amplification. Large libraries containing ~10^8 independent E. coli transformants allow isolation of specific monoclonal antibodies from immunoglobulin repertoires. Creative Bio Labs develops engineered protein scaffold libraries for high-affinity binder isolation in research, diagnosis, and therapy. Their trimer coding technology enables precise site-directed mutant library construction. Constrained peptide libraries generate natural or semi-synthetic peptides with stabilized structures using positional stabilization, positional cyclization, and phage display methods. Lambda phage genome library construction services offer additional capabilities for comprehensive genomic analysis.

Combinatorial libraries require systematic selection methods to identify functional variants, with SELEX and phage display being the primary approaches; SELEX involves iterative rounds of binding, washing, and amplification to enrich RNA/DNA binders, while phage display uses filamentous phage particles to display proteins on surfaces for selection against targets; key quantitative metrics include enrichment (ratio of hit frequency before and after selection), specificity (selection preference for hits over non-hits), and recovery (efficiency of hit retention); additional methods like ribosome display, cell surface display, complementation selections, and synthetic selections provide alternative strategies for linking genotype to phenotype, with dual selections enabling conditional activity screening.

The phage display screening workflow follows a systematic multi-step process: First, target molecules (preys) such as proteins or DNA are immobilized on solid supports. Second, a diverse library of phage particles displaying different proteins is incubated with the immobilized targets. Third, unbound phages are removed through washing. Fourth, bound phages carrying interacting proteins are eluted. Fifth, these selected phages are amplified in bacterial culture due to the phage-bacteria relationship. Finally, the recovered phages are analyzed to identify which displayed proteins bind specifically to the target. This approach enables high-throughput identification of molecular interaction partners.

Microbiologists use multiple methods to isolate mutants: antibiotic resistance selection uses media containing antibiotics to isolate resistant bacteria; phage resistance selection uses media containing bacteriophages; replica plating transfers colonies from complete to minimal media to identify auxotrophic mutants that fail to grow without specific nutrients; penicillin enrichment selects auxotrophic mutants that survive penicillin treatment but cannot grow. These methods exploit the differential growth requirements between wild-type and mutant organisms to isolate specific genetic variants for study.

Site-directed mutagenesis is a molecular biology technique that deliberately introduces specific mutations at predetermined sites in DNA sequences using primer-directed DNA synthesis, enabling researchers to study gene function by creating targeted genetic changes and observing the resulting biological effects; the process involves designing primers containing the desired mutation, using them to synthesize complementary DNA strands, and introducing the mutated DNA into host organisms through transformation, where the host's repair machinery seals any nicks formed during replication.

Site-directed mutagenesis is a molecular biology technique that enables researchers to introduce specific, targeted mutations at precise locations within a gene sequence, allowing them to study the relationship between genetic changes and protein function; this is achieved through methods such as PCR-based mutagenesis (using custom-designed oligonucleotides with mutations flanked by homologous regions), overlap extension PCR (sewing) for introducing single point mutations, and commercial kits like QuickChange that utilize DpnI digestion to eliminate the original plasmid while preserving the mutated version.

Site-directed mutagenesis is a genetic modification technique for generating amino acid coding changes in DNA genes. The three basic mutation types are substitution (replacing one component with another), insertion (adding new components), and deletion (removing components). Oligonucleotide-containing directed mutagenesis integrates PCR into the process, using short DNA pieces (10-30 nucleotides) containing desired mutations. The process involves using M13 bacteriophage with single-stranded DNA, inserting the gene of interest with changes, creating mismatched base pairs, forming double-stranded DNA with outer and inner strands, substituting nucleotides in the outer strand, and inserting mRNA into host cells to generate both normal and mutated protein types.

This comprehensive section details the oligonucleotide-directed site-directed mutagenesis method. It requires two key components: synthetic oligonucleotides (10-30 nucleotides long) containing a single base change compared to the target gene, and plasmid vectors as DNA carriers. The procedure involves: (1) inserting the target gene into a plasmid vector to create a recombinant plasmid, (2) denaturing the plasmid to separate DNA strands, (3) annealing the mutant oligonucleotide to the single-stranded template, (4) using DNA polymerase to extend and complete the new DNA strand incorporating the mutation, (5) transforming the mutated plasmid into bacterial cells, and (6) allowing bacterial replication to produce both wild-type and mutated gene copies, ultimately yielding modified enzyme proteins.

PCR can be used to introduce deliberate mutations into DNA sequences through site-directed mutagenesis. By intentionally introducing single-base mismatches into primer sequences, researchers can incorporate additional nucleotides into the amplified DNA over successive PCR cycles. These extra sequences can encode specific mutations or create target sites for molecular scissors (restriction enzymes). This technique allows scientists to swap genetic control blocks between organisms by amplifying separate regions, cutting them to create compatible sticky ends, and joining them together—a fundamental tool for genetic engineering.

Twist Bioscience presents its comprehensive portfolio spanning synthetic biology and next-generation sequencing solutions. The core technology uses a chip-based platform (same footprint as 96-well plate) to manufacture over one million unique DNA oligos with error rates of ~1/2,000 nucleotides and excellent uniformity. This enables diverse applications including gene synthesis (up to 1.8 KB fragments, 5 KB clonal inserts), CRISPR guide RNA libraries, and amino acid variant libraries. Twist's variant library technology provides significant advantages over degenerate synthesis by distinctly defining every library member without sequence-dependent biases. Single site libraries enable systematic mutation analysis (deep mutational scans) by changing one amino acid position at a time. Combinatorial libraries achieve over 10 billion variants using domain-style and spread-out strategies. For NGS, Twist offers library preparation (enzymatic and mechanical fragmentation), adapter systems (combinatorial dual-index, universal dual-index, UMI), and target enrichment panels including comprehensive exomes, viral panels, and methylation panels. Synthetic controls include viral controls and cell-free DNA reference controls with controlled variants at 0.1-5% allele frequencies.

NGS library preparation begins with DNA or RNA samples, where RNA is converted to cDNA using reverse transcriptase. Fragments are ligated with universal adapters enabling sequencing machinery binding. The library is loaded onto a sequencing chip where fragments form clusters monitored by high-resolution cameras. Sequencing generates paired-end reads (150 bases each from 400-base fragments). After sequencing, reads are aligned to reference genome (GRCH38 standard from NCBI). Variant calling identifies alterations by comparing reference bases to sequencing data. Allele fraction calculation determines heterozygous (~0.5) vs homozygous (~1.0) mutations. Copy number alterations are detected by comparing read coverage to average coverage. Gene fusions are identified when read pairs map to different chromosomes or distant regions. Different genomic sequencing approaches target different regions: whole genome sequencing covers all 3.1 billion base pairs (expensive), whole exome targets coding DNA, whole transcriptome analyzes RNA transcripts, and targeted gene panels focus on specific biomarkers (10-500 genes) for cost-effective clinical applications. Standard file formats enable global communication: FASTQ contains raw sequencing data with four-line structure (sequence ID, nucleotide sequence, plus symbol, quality scores). Phred+33 encoding uses single-character symbols for quality scores (40 = 1 in 10,000 error rate). SAM stores aligned reads as text, BAM as compressed binary. VCF reports variants with headers containing metadata and entries including chromosome, position, alleles, and RS IDs from dbSNP database. Mutations are annotated at different levels using specific conventions: 'g.' indicates genomic coordinates, 'c.' indicates cDNA/transcript coordinates, 'p.' indicates protein coordinates. The BWA-GATK pipeline is the most widely used best practice for NGS analysis. Steps include: BWA alignment to reference genome, marking/removing PCR duplicates using Picard tools, indel realignment around known indel sites, base quality score recalibration (BQSR) to correct Illumina platform biases, variant calling using GATK HaplotypeCaller, and variant filtering/annotation. PCR duplicate removal is critical because over-amplified fragments can create false positive variant calls. Indel realignment corrects alignment artifacts where standard algorithms produce inconsistent gap placements. BQSR addresses systematic biases where certain bases receive inflated quality scores. Variant classification determines germline vs somatic status using paired normal tissue or databases (COSMIC for somatic, dbSNP for germline). Variants are classified as pathogenic (therapeutic targets), benign (ignored), or variants of unknown significance (VUS) requiring research. Functional annotation uses computational tools (PolyPhen, SIFT, PROVEAN) and databases (dbNSFP) considering biochemical properties, evolutionary conservation, and protein domain location. In typical exome sequencing, 30,000-40,000 variants are identified, but only ~100 are likely driver mutations. Filtering strategies include minimum allele fraction (5x coverage threshold), germline variant removal, and functional score thresholds. Driver mutations are identified by comparing functionally significant mutations against biological and clinical knowledge.

Next Generation Sequencing (NGS) is a revolutionary technology for determining DNA sequences that differs fundamentally from traditional Sanger sequencing. NGS generates vastly more data, capable of sequencing up to 20 times the human genome in a single run compared to Sanger's 96 samples per run. The workflow consists of four essential steps: library construction, amplification, sequencing, and data analysis. Library construction serves three critical purposes: generating appropriately sized fragments (typically 200-300 bp), adding adapters to fragment ends, and incorporating sample identifiers. DNA fragmentation can be achieved through enzymatic digestion, mechanical shearing, or PCR amplification, with PCR-based fragmentation being preferred for its versatility in targeting specific genomic regions. Ultra-high multiplex PCR enables simultaneous amplification of hundreds to thousands of specific fragments in a single reaction, making library construction more efficient.

Library complexity refers to the fraction of non-redundant DNA fragments in a sequencing library. High-quality libraries should have most reads aligning uniquely to one genomic position (ideally >90%). Low complexity libraries show high percentages of clonal reads (identical reads aligning to the same position), resulting from low DNA recovery, PCR amplification bias, sequencing bias, or adapter dimer contamination. ENCODE standards consider libraries with <50% non-redundant reads concerning, 50-80% acceptable, and >80% compliant. Tools like HOMER report reads per position to assess complexity.

This comprehensive section covers the foundational concepts of Next-Generation Sequencing and bioinformatics. The lecture explains how NGS reads DNA fragments nucleotide by nucleotide using fluorescently labeled nucleotides, generating digitized reads that must be mapped to reference genomes. Key terminology includes genetic variants, alleles, and reference alleles. The bioinformatics pipeline transforms raw binary data (BAM/BISL files) into interpretable FASTQ files, then through automated programs to variant lists. The pipeline architecture consists of 15-30 programs running on Linux systems, requiring command-line operation. Processing time ranges from hours to days depending on data volume. Read mapping determines where each DNA read originated in the reference genome. Coverage depth indicates how many times each genomic position was sequenced, while coverage width measures what percentage of target regions achieved minimum depth. Coverage is never uniform due to polymerase errors and DNA structure variations. For somatic mutation detection, 100x+ coverage is needed compared to 10x+ for germline variants. Sequencing artifacts arise from PCR errors, mapping errors in complex genomic regions, and systematic biases. PCR duplicates occur when the same DNA fragment is sequenced multiple times. Sequencing technologies struggle with repetitive DNA regions and homologous gene regions because short reads cannot be uniquely mapped to the genome.